|Articles|January 5, 2023
Egnyte Announces New Offering for Early-Stage Life Science Startups
Company provides startup biotechs access to collaboration platform for a year.
Advertisement
Egnyte announced it will be providing early-stage life sciences innovators complimentary access to their Egnyte for Life Sciences platform. This offer is designed to accelerate “time to patient” for life sciences innovators and will give companies a full year of access to Egnyte’s platform.
Read more about the new offering
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
2
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
3
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
4
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
5